Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGM - Nasdaq Real Time Price USD

Verona Pharma plc (VRNA)

Compare
60.29
+1.75
+(2.99%)
At close: 4:00:00 PM EDT
59.97
-0.32
(-0.53%)
After hours: 5:10:23 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
42,279
42,279
--
458
40,000
Cost of Revenue
2,582
2,582
--
346
--
Gross Profit
39,697
39,697
--
112
40,000
Operating Expense
190,724
190,724
66,465
66,228
97,683
Operating Income
-151,027
-151,027
-66,465
-66,116
-57,683
Net Non Operating Interest Income Expense
-8,280
-8,280
10,704
2,300
-326
Other Income Expense
-3,822
-3,822
1,866
-4,632
2,422
Pretax Income
-163,129
-163,129
-53,895
-68,448
-55,587
Tax Provision
10,289
10,289
474
253
-18
Net Income Common Stockholders
-173,418
-173,418
-54,369
-68,701
-55,569
Diluted NI Available to Com Stockholders
-173,418
-173,418
-54,369
-68,701
-55,569
Basic EPS
-2.16
--
-0.72
-1.04
-0.96
Diluted EPS
-2.16
--
-0.72
-1.04
-0.96
Basic Average Shares
81,538.82
--
79,267.83
66,133.94
59,148.56
Diluted Average Shares
81,538.82
--
79,267.83
66,133.94
59,148.56
Total Operating Income as Reported
-154,627
-154,627
-67,569
-75,750
-73,313
Total Expenses
193,306
193,306
66,465
66,574
97,683
Net Income from Continuing & Discontinued Operation
-173,418
-173,418
-54,369
-68,701
-55,569
Normalized Income
-170,551.50
-170,551.50
-55,880.46
-64,949.08
-57,988.58
Interest Income
15,262
15,262
12,761
2,821
14
Interest Expense
23,542
23,542
2,057
521
340
Net Interest Income
-8,280
-8,280
10,704
2,300
-326
EBIT
-139,587
-139,587
-51,838
-67,927
-55,247
EBITDA
-138,529
-138,529
-51,161
-67,291
-54,618
Reconciled Cost of Revenue
2,582
2,582
--
346
--
Reconciled Depreciation
1,058
1,058
677
636
629
Net Income from Continuing Operation Net Minority Interest
-173,418
-173,418
-54,369
-68,701
-55,569
Total Unusual Items Excluding Goodwill
-3,822
-3,822
1,866
-4,632
2,422
Total Unusual Items
-3,822
-3,822
1,866
-4,632
2,422
Normalized EBITDA
-134,707
-134,707
-53,027
-62,659
-57,040
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-955.50
-955.50
354.54
-880.08
2.42
12/31/2021 - 4/28/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EWTX Edgewise Therapeutics, Inc.
15.52
-22.90%
 
SRRK Scholar Rock Holding Corporation
32.54
+8.25%
 
MDGL Madrigal Pharmaceuticals, Inc.
334.60
+3.28%
 
BBIO BridgeBio Pharma, Inc.
34.62
+4.85%
 
CYTK Cytokinetics, Incorporated
40.25
+7.33%
 
INSM Insmed Incorporated
73.44
+2.00%
 
AXSM Axsome Therapeutics, Inc.
109.75
-1.72%
 
SWTX SpringWorks Therapeutics, Inc.
46.52
+11.08%
 
WVE Wave Life Sciences Ltd.
7.57
-2.20%
 
RNA Avidity Biosciences, Inc.
29.77
+11.33%